Aurobindo Pharma to commence supplies to Europe from China facility from April

17 Feb 2025 Evaluate

Aurobindo Pharma is all set to commence supplies to Europe from its China facility from April onwards. The Hyderabad-based drug maker commenced operations at the facility in the last week of November 2024 and is now ramping up the production. The company has received European regulatory approvals and can initiate product supply to the market. The company expects good traction coming out of the China plant over the next 2-3 years.

Aurobindo Pharma is engaged in manufacturing pharmaceutical products. It offers active pharmaceutical ingredients, intermediates and generic formulations like astemizole, domeperidone and omeprazole; anti-infective, oral and sterile antibiotics, pain management and osteoporosis segments.

Aurobindo Pharma Share Price

1171.00 9.15 (0.79%)
10-Dec-2025 15:41 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1789.45
Dr. Reddys Lab 1249.70
Cipla 1489.15
Zydus Lifesciences 919.00
Lupin 2054.55
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×